Garuda - Garba Rujukan Digital

Baiq Sofianti Annisa

Unknown Affiliation

Author-ID : 3495133

Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document

Claim Missing Document

Articles

1

Profil penggunaan obat antidiabetes pada pasien diabetes mellitus tipe 2 di instalasi rawat jalan RSUD Provinsi NTB tahun 2018 Baiq Sofianti Annisa; Candra Eka Puspitasari; Siti Rahmatul Aini
Sasambo Journal of Pharmacy Vol. 2 No. 1 (2021): April
Publisher : Universitas Mataram

Diabetes mellitus (DM) is a disorder of insulin secretion, insulin action or both, which are characterized by blood glucose levels > 200 mg/dl and / or fasting blood glucose levels > 126 mg/dl. In 2017 Indonesia was recorded as the sixth largest country with DM in the world. The most common classification of diabetes is type 2 DM with an incidence 90-95%. The study aimed to determine the profile of antidiabetic use in type 2 DM patients at the outpatient installation of RSUD Provinsi NTB in 2018. This study used cross sectional design retrospectively with purposive sampling method for the period January-December 2018. The results showed that in 112 patients, 195 antidiabetic agents were prescribed. The antidiabetic prescribed were metformin (33.85%), glimepirid (25.13%), aspart insulin (13.33%), insulin detemir (8.21%), pioglitazone (6.67%), insulin glargine (6.67%), glyclazide (1.54%), gliquidone (1.54%), acarbose (1.54), regular insulin (1.03%), and insulin lispro (0.51%). Overall, antidiabetic use was in accordance with the guideline recommendations. Further research is needed regarding the review of prescriptions and detailed indications in order to increase rationality of drug use, reduce morbidity and mortality and reduce medical costs.

Profil Drud Related Problems (DRPs) pada Pasien Diabetes Melitus Tipe 2 di Instalasi Rawat Jalan Rumah Sakit X Provinsi Nusa Tenggara Barat Tahun 2018 Candra Eka Puspitasari; Baiq Sofianti Annisa; Siti Rahmatul Aini; Arfi Syamsun; Zulkarnain; Melda Putri Zakiyah
Pharmaceutical Journal of Indonesia Vol. 9 No. 1 (2023)
Publisher : Brawijaya University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.pji.2023.009.01.6

Type 2 diabetes mellitus’s patients often receive polypharmacy therapy to prevent complications, but this has the potential effect to increase Drug Related Problems (DRPs). This study aims to evaluate the incidence of DRPs in type 2 diabetes mellitus’s patients at the Outpatient Installation of X Hospital in NTB Province in 2018. This research was conducted with a retrospective cross-sectional design with a sampling technique, namely purposive sampling. After the data is obtained, then classification of the problems and causes of DRPs is carried out based on the Pharmaceutical Care Network Europe Foundation Version 8.03 (PCNE V8.03). The results obtained 112 patients where 80 patients experienced DRPs events with a total of 224 DRPs events. The pattern of anti-diabetic use was dominated by the Biguanide group, namely Metformin (33.85%), followed by Insulin (29.75%), and Sulfonylureas (28.21%). Insulin use was dominated by Insulin Aspart (13.33%), while Sulfonylureas were dominated by Glimepiride (25.13%). Therefore, DRPs that occur sequentially are the categories of adverse drug effects that may occur (66.52%), drugs without indication (15.63%), drugs that are not appropriate according to guidelines/formularies (7.14%), symptoms or indications not treated (4.91%), the frequency of using the dose was insufficient (1.79%), the frequency of using the dose was too frequent (1.79%), the drug dose was too low (1.34%), too many drugs were prescribed for indications (0.45%) and the drug dose is too high (0.45%).

Profil Drud Related Problems (DRPs) pada Pasien Diabetes Melitus Tipe 2 di Instalasi Rawat Jalan Rumah Sakit X Provinsi Nusa Tenggara Barat Tahun 2018 Candra Eka Puspitasari; Baiq Sofianti Annisa; Siti Rahmatul Aini; Arfi Syamsun; Zulkarnain; Melda Putri Zakiyah
Pharmaceutical Journal of Indonesia Vol. 9 No. 1 (2023)
Publisher : Brawijaya University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.pji.2023.009.01.6

Type 2 diabetes mellitus’s patients often receive polypharmacy therapy to prevent complications, but this has the potential effect to increase Drug Related Problems (DRPs). This study aims to evaluate the incidence of DRPs in type 2 diabetes mellitus’s patients at the Outpatient Installation of X Hospital in NTB Province in 2018. This research was conducted with a retrospective cross-sectional design with a sampling technique, namely purposive sampling. After the data is obtained, then classification of the problems and causes of DRPs is carried out based on the Pharmaceutical Care Network Europe Foundation Version 8.03 (PCNE V8.03). The results obtained 112 patients where 80 patients experienced DRPs events with a total of 224 DRPs events. The pattern of anti-diabetic use was dominated by the Biguanide group, namely Metformin (33.85%), followed by Insulin (29.75%), and Sulfonylureas (28.21%). Insulin use was dominated by Insulin Aspart (13.33%), while Sulfonylureas were dominated by Glimepiride (25.13%). Therefore, DRPs that occur sequentially are the categories of adverse drug effects that may occur (66.52%), drugs without indication (15.63%), drugs that are not appropriate according to guidelines/formularies (7.14%), symptoms or indications not treated (4.91%), the frequency of using the dose was insufficient (1.79%), the frequency of using the dose was too frequent (1.79%), the drug dose was too low (1.34%), too many drugs were prescribed for indications (0.45%) and the drug dose is too high (0.45%).

Title

Found 3 Documents
Search

Abstract

Abstract

Abstract

Title Search

Found 3 Documents Search

Abstract

Abstract

Abstract

Title

Found 3 Documents
Search